title: The role of intravenous iron in the treatment of anemia in cancer patients.
abstract: Anemia is a major cause of morbidity in cancer patients resulting in poor physical performance, prognosis and therapy outcome. Initially, erythropoietin-stimulating agents (ESAs) were supposed to be the treatment of choice but about one third of patients turned out to be nonresponders and meta-analyses provided evidence of an increased risk of mortality if used excessively. This along with the successful use of intravenous iron for anemia in patients with chronic kidney disease prompted seven clinical studies evaluating the efficacy of intravenous iron as an adjunct to ESAs and four additional studies using intravenous iron only for anemia in cancer patients. These studies confirmed a superior response if ESAs are combined with intravenous iron and revealed iron only to be a useful option in patients with mild and absolute iron deficiency (AID). Currently, best treatment decisions for anemia in cancer might be based on measurements of serum ferritin (SF), transferrin saturation (TSAT), soluble transferrin receptor (sTfR), ferritin index (FI = sTfR/log SF), hypochromic reticulocytes (CHR) and C-reactive protein (CRP). However, there is still an urgent need for trials investigating diagnostic approaches to optimize therapy of anemia in cancer patients with iron and/or ESAs.
authors.affiliation: Outpatient Clinic for Hematology and Oncology, Sachsenring 69, 50677 Cologne, Germany.
authors.forename: H Tilman
authors.initials: HT
authors.lastname: Steinmetz
keywords: anemia of chronic disease; cancer; hemoglobin; iron deficiency
references.citation: Oncologist. 2007 Jun;12(6):748-55
references.pmid: 17602064
references.citation: Am J Kidney Dis. 1995 Jul;26(1):41-6
references.pmid: 7611266
references.citation: J Clin Oncol. 2008 Apr 1;26(10):1611-8
references.pmid: 18375890
references.citation: Br J Cancer. 2010 Jan 19;102(2):301-15
references.pmid: 20051958
references.citation: Int J Lab Hematol. 2011 Apr;33(2):187-93
references.pmid: 20868446
references.citation: J Clin Oncol. 2008 Apr 1;26(10):1619-25
references.pmid: 18375891
references.citation: J Clin Oncol. 2011 Jun 10;29(17):e525-6; author reply e527-8
references.pmid: 21537041
references.citation: Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):705-15
references.pmid: 11395239
references.citation: Eur J Cancer. 2007 Jan;43(2):258-70
references.pmid: 17182241
references.citation: Lancet. 2009 May 2;373(9674):1532-42
references.pmid: 19410717
references.citation: Blood. 2010 Nov 18;116(20):4045-59
references.pmid: 20974674
references.citation: Clin Chem. 2002 Jul;48(7):1066-76
references.pmid: 12089176
references.citation: Br J Rheumatol. 1994 Aug;33(8):740-4
references.pmid: 8055201
references.citation: Support Care Cancer. 2014 Aug;22(8):2197-206
references.pmid: 24659244
references.citation: J Clin Oncol. 1997 Mar;15(3):1218-34
references.pmid: 9060566
references.citation: Nephrol Dial Transplant. 2005 Jul;20(7):1443-9
references.pmid: 15855210
references.citation: Support Care Cancer. 2010 Feb;19(2):261-9
references.pmid: 20148270
references.citation: J Biol Chem. 2001 Mar 16;276(11):7806-10
references.pmid: 11113131
references.citation: Blood. 2002 Oct 1;100(7):2303-20
references.pmid: 12239138
references.citation: Nephrol Dial Transplant. 1996 Feb;11(2):319-22
references.pmid: 8671786
references.citation: Curr Med Res Opin. 2008 Oct;24(10):2751-6
references.pmid: 18715527
references.citation: Blood. 2010 Dec 2;116(23):4754-61
references.pmid: 20826717
references.citation: Oncologist. 2007 Feb;12(2):231-42
references.pmid: 17296819
references.citation: Leukemia. 2007 Apr;21(4):627-32
references.pmid: 17252006
references.citation: Am J Med. 1989 Dec;87(6):638-44
references.pmid: 2589399
references.citation: Crit Rev Clin Lab Sci. 2000 Apr;37(2):93-130
references.pmid: 10811141
references.citation: Kidney Int. 1996 Nov;50(5):1694-9
references.pmid: 8914038
references.citation: Am J Clin Nutr. 2004 Mar;79(3):437-43
references.pmid: 14985219
references.citation: J Clin Oncol. 2011 Jan 1;29(1):97-105
references.pmid: 21098317
references.citation: Eur J Cancer. 2004 Oct;40(15):2293-306
references.pmid: 15454256
references.citation: J Clin Oncol. 2011 Sep 1;29(25):3343-4
references.pmid: 21788569
references.citation: Oncologist. 2008;13 Suppl 3:33-6
references.pmid: 18458123
references.citation: Clin Chem. 2002 Jul;48(7):1118-21
references.pmid: 12089189
references.citation: Radiology. 1996 Nov;201(2):553-8
references.pmid: 8888257
references.citation: Gynecol Oncol. 2007 Apr;105(1):199-204
references.pmid: 17234260
references.citation: Am J Hematol. 2010 Sep;85(9):655-63
references.pmid: 20661916
references.citation: J Clin Oncol. 2001 Jun 1;19(11):2865-74
references.pmid: 11387359
references.citation: Med Oncol. 2008;25(1):12-21
references.pmid: 18188710
references.citation: Lancet. 2007 May 5;369(9572):1502-1504
references.pmid: 17482969
references.citation: N Engl J Med. 2005 Mar 10;352(10):1011-23
references.pmid: 15758012
references.citation: FEBS Lett. 2000 Sep 1;480(2-3):147-50
references.pmid: 11034317
references.citation: Haematologica. 2002 Nov;87(11):1209-21
references.pmid: 12414352
references.citation: Oncologist. 2005 Oct;10(9):743-57
references.pmid: 16249356
references.citation: J Clin Oncol. 2004 Apr 1;22(7):1301-7
references.pmid: 15051778
references.citation: J Clin Oncol. 2010 Nov 20;28(33):4996-5010
references.pmid: 20975064
references.citation: BMJ. 2003 May 24;326(7399):1124
references.pmid: 12763985
references.citation: Eur J Haematol. 2006 Nov;77(5):378-86
references.pmid: 17044835
references.citation: Curr Oncol. 2007 Oct;14(5):209-17
references.pmid: 17938704
references.citation: Nephrol Dial Transplant. 2006 Feb;21(2):378-82
references.pmid: 16286429
references.citation: Best Pract Res Clin Haematol. 2002 Jun;15(2):411-26
references.pmid: 12401315
references.citation: Anesthesiology. 2008 Dec;109(6):951-3
references.pmid: 19034088
references.citation: Arthritis Rheum. 2000 May;43(5):1016-20
references.pmid: 10817554
references.citation: J Clin Oncol. 1995 Aug;13(8):2077-83
references.pmid: 7636551
references.citation: Blood. 1997 Feb 1;89(3):1052-7
references.pmid: 9028338
references.citation: Br J Haematol. 1992 Mar;80(3):278-84
references.pmid: 1581207
references.citation: Eur J Cancer Care (Engl). 2011 Jul;20(4):493-502
references.pmid: 21029222
references.citation: Gynecol Oncol. 2010 Mar;116(3):522-5
references.pmid: 20051288
references.citation: J Clin Oncol. 2002 Jan 15;20(2):601-3
references.pmid: 11786593